Page 9 - Wanda Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: Dr. Yuntao Cui; Dr. Jin Wang; Mr. Henry

(Bloomberg) -- Abu Dhabi Investment Authority is considering buying a minority stake in Dalian Wanda Group Co.’s mall operator, people familiar with the matter said, as the unit revamps its shareholding structure.Most Read from BloombergKing Charles Treated for Cancer in New Health Scare for MonarchyWhy NYC Apartment Buildings Are on Sale Now for 50% OffChina Tightens Some Trading Restrictions for Domestic and Offshore InvestorsEastern Europe’s Richest Woman Pivots $43 Billion Empire WestBonds F

A tale of corporate dysfunction is banking on Chinese audiences’ concerns over the country’s economic prospects as Gen Zers shun the office and "lie flat."

(Bloomberg) -- Most Read from BloombergMike Johnson May Be the Next House Speaker to Lose His JobHarvard College Early Applications Drop 17% From Last YearChina’s iPhone Ban Accelerates Across Government and State Firms‘Underwater’ Car Loans Signal US Consumers Slammed by High RatesNetanyahu, Under Pressure Over Hostage Deaths, Vows to Press On Private equity giants are turning to a new take on an old solution to higher debt costs for M&A deals: borrow all of the money they can and defer paying

HONG KONG: China's embattled Country Garden said it will sell a small stake in a Dalian Wanda unit back to the Dalian Wanda Group, with the proceeds of about US$428 million going to